GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Artificial Intelligence /AI ML-based nomogram for mortality risk stratification in cirrhotic patients
35

AI ML-based nomogram for mortality risk stratification in cirrhotic patients

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated November 1, 2025

The AI/ML-based nomogram developed in this study serves as a predictive tool for estimating in-hospital mortality risk among cirrhotic patients with sepsis. This retrospective single-center study analyzed data from 264 patients admitted between January 2018 and July 2025, dividing them into Survivor and Non-survivor groups, with 28.4% succumbing to the condition during hospitalization. To ensure robust model performance, the dataset was split into a training set (70%) and validation set (30%).

Key predictors of mortality identified included alcoholic cirrhosis, Child-Pugh score, mechanical ventilation, total bilirubin (TBiL), and heart rate (HR). These factors were selected using LASSO regression and further optimized with multivariate logistic regression. A nomogram was constructed to visually quantify individual mortality risks based on the weighted contribution of these predictors. The model demonstrated excellent discrimination with an AUC of 0.81 in the training set and 0.83 in the validation set, while calibration plots showed strong agreement between predicted and observed outcomes.

Alcoholic cirrhosis was a significant risk factor, with a 3.7 times higher mortality rate compared to non-alcoholic cases. Higher Child-Pugh scores indicated worsening prognosis, mechanical ventilation doubled mortality risk, and elevated TBiL levels reflected impaired hepatic function. Extreme heart rate abnormalities also correlated with poor outcomes. Infection complications like spontaneous bacterial peritonitis and esophageal variceal bleeding were more frequent among non-survivors.

The nomogram provides clinicians with a quantitative tool for mortality risk stratification, enabling early intervention strategies. Its findings align with global trends in cirrhosis-related mortality, emphasizing its clinical relevance and utility in managing high-risk patients effectively.

Related Q&A

36

Deep learning : Predicting HCC surgery success with multimodal imaging

Deep learning is a subset of machine learning that uses artificial neural networks to model and analyze complex data patterns. It is particularly effective in tasks involving large...

37

Artificial intelligence-assisted colonoscopy improves adenoma detection rates

Yes, artificial intelligence (AI)-assisted colonoscopy has been shown to improve adenoma detection rates (ADR). Adenoma detection is a critical measure in colonoscopy, as higher ADRs are directly linked...

38

Esophageal Squamous Cell Carcinoma, Post operative Recurrence and Machine Learning

Esophageal squamous cell carcinoma (ESCC) is a common and aggressive form of cancer, with a high risk of postoperative recurrence. Accurate prediction of recurrence is essential for optimizing...

39

Machine learning (ML) in GI Endoscopy

Machine learning (ML) in gastrointestinal (GI) endoscopy is revolutionizing the field by improving diagnostic precision, reducing human variability, and enhancing workflow efficiency. Here is a detailed explanation of...

40

AI in health and health care: summary of the JAMA Summit

The JAMA Summit on AI in health and health care highlighted the transformative impact of artificial intelligence on the field, emphasizing its potential to improve access, quality, and...

41

Integrating Machine Learning and Bioinformatics to Develop a Gene-Based Prognostic Model for Gastric Cancer

Integrating machine learning and bioinformatics has proven to be a transformative approach in developing a gene-based prognostic model for gastric cancer. This study utilized transcriptomic and clinical data...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer